Transcatheter aortic valve implantation (TAVI) has spawned the evolution of novel catheter-
based therapies for a variety of cardiovascular conditions. Newer device iterations are …

Registry data that shows a clinically meaningful association of higher mortality and other
major complications with site annual volume below the recommended threshold of 50 …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

Background—We aimed to determine the incidence, predictors, clinical characteristics,
management, and outcomes of infective endocarditis (IE) after transcatheter aortic valve …

Transcatheter aortic valve replacement (TAVR) has become a safe and effective therapy for
patients with severe aortic stenosis (AS). In recent trials, the hemodynamic performance and …

Transcatheter aortic valve implantation (TAVI) or replacement has rapidly changed the
treatment of patients with severe symptomatic aortic stenosis. It is now the standard of care …

Objectives Mitral regurgitation (MR) is a common entity in patients with aortic stenosis
undergoing transcatheter aortic valve replacement (TAVR), but its influence on outcomes …

Objectives The purpose of this study was to examine the impact of residual mitral
regurgitation (MR) on mortality in patients undergoing transcatheter aortic valve replacement …

Objectives: This study sought to analyze the clinical impact of the degree and improvement
of mitral regurgitation in TAVR recipients, validate the main imaging determinants of this …